Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2012 09:30 ET | Source: Sonoma Pharmaceuticals, Inc.

Oculus Innovative Sciences, Inc. to Raise $3.1 Million in Registered Direct Offering

PETALUMA, Calif., April 23, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced today that it has entered into a definitive agreement with a single life science-focused...
April 19, 2012 08:08 ET | Source: Sonoma Pharmaceuticals, Inc.

Photo Release -- Napa Valley Nutritionals, a Newly Formed Division of Oculus Innovative Sciences, Introduces Glucorein(TM) Medical Food for Management of Glucose Levels in Pre-Diabetics and Type 2 Diabetics

PETALUMA, Calif., April 19, 2012 (GLOBE NEWSWIRE) -- Napa Valley Nutritionals™ (www.nvnutritionals.com) headquartered in Sacramento, California, a newly created division of Oculus...
March 23, 2012 08:08 ET | Source: Sonoma Pharmaceuticals, Inc.

Oculus Innovative Sciences Provides Business Update From Roth Capital 23rd Annual Growth Conference

PETALUMA, Calif., March 23, 2012 (GLOBE NEWSWIRE) -- In compliance with SEC Regulation FD requirements or "fair disclosure" of material information, Hoji Alimi, founder and CEO of Oculus Innovative...
March 06, 2012 08:08 ET | Source: Sonoma Pharmaceuticals, Inc.

Oculus Innovative Sciences Partner, Eloquest Healthcare, Launches Microcyn(R) Wound Care Products Into U.S. Hospitals, Ambulatory Surgical and Acute Care Centers

PETALUMA, Calif., March 6, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) partner, Eloquest Healthcare, today launched the Eloquest-branded family of Microcyn® wound care...
February 21, 2012 08:08 ET | Source: Sonoma Pharmaceuticals, Inc.

Oculus Innovative Sciences Partner, Quinnova Pharmaceuticals, Launches Microcyn(R)-Based Atrapro(TM) Products

PETALUMA, Calif., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) partner, Quinnova Pharmaceuticals, today launched the Atrapro™ family of products formulated...
February 02, 2012 16:05 ET | Source: Sonoma Pharmaceuticals, Inc.

Oculus Innovative Sciences Reports Fiscal Third Quarter 2012 Financial Results

PETALUMA, Calif., Feb. 2, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced financial results for the third quarter of fiscal year 2012, ended December 31, 2011....
January 19, 2012 08:08 ET | Source: Sonoma Pharmaceuticals, Inc.

Oculus Innovative Sciences Announces Fiscal Third Quarter 2012 Financial Results and Conference Call

PETALUMA, Calif., Jan. 19, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced that the financial results for its fiscal third quarter 2012, ended December 31,...
December 29, 2011 08:08 ET | Source: Sonoma Pharmaceuticals, Inc.

Oculus Innovative Sciences to Present at Biotech Showcase 2012 in San Francisco

PETALUMA, Calif., Dec. 29, 2011 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced that the company's president and founder, Hoji Alimi, will present at Biotech...
December 23, 2011 08:08 ET | Source: Sonoma Pharmaceuticals, Inc.

Oculus Innovative Sciences, Inc. to Raise Approximately $2.0 Million in Registered Direct Offering

PETALUMA, Calif., Dec. 23, 2011 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced it has received commitments from certain institutional and accredited investors to...
November 03, 2011 16:05 ET | Source: Sonoma Pharmaceuticals, Inc.

Oculus Innovative Sciences Reports Record Fiscal Second Quarter 2012 Financial Results

PETALUMA, Calif., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced financial results for the second quarter of fiscal year 2012, ended September 30,...